Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Caporex Oy
OY
Dissolved
Y-tunnus 0953274-0
Pl 12, 00931
Helsinki
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1993 · 32 years old
0 employees
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Caporex Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2024
0M
2025
EBITDA
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2024
0M
0%
2025
Income statement
EUR thousands
Item
2020
2021
2022
2024
2025
Revenue
8
9
3
0
0
Staff expenses
—
—
—
−0
−0
EBITDA
−0
2
−5
−7
−8
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−0
2
−5
−7
−8
Net financials
−54
20
37
−37
45
Profit before tax
−54
21
32
44
37
Tax
1
0
−0
−0
−0
Net profit
−55
21
32
44
37
Balance sheet
EUR thousands
Item
2020
2021
2022
2024
2025
Total assets
98
118
150
110
149
Equity
34
55
87
40
77
Long-term debt
—
—
—
0
0
Short-term debt
64
63
63
70
72
Total debt
64
63
63
70
72
Financial ratios
5-year trend
EBITDA margin
-768000.0%
This company
15.8%
Market median
-4860859% vs market
2020
2025
Equity ratio
51.5%
This company
38.2%
Market median
+35% vs market
2020
2025
Return on equity
48.4%
This company
18.4%
Market median
+163% vs market
2020
2025
Net profit margin
3720100.0%
This company
8.1%
Market median
+45927060% vs market
2020
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2025
Debt / equity
0.94×
This company
0.62×
Market median
+52% vs market
2020
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2024-04-01 – 2025-03-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2023-04-01 – 2024-03-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2021-04-01 – 2022-03-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2020-04-01 – 2021-03-31
View
PDF
Annual report 2020
Filed via PRH / YTJ · Period 2019-04-01 – 2020-03-31
View
PDF
More on Caporex Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
